We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
-12.6%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$206M
AUM Growth
-$62.9M
Cap. Flow
-$30.8M
Cap. Flow %
-14.93%
Top 10 Hldgs %
60.1%
Holding
77
New
7
Increased
15
Reduced
39
Closed
11

Top Buys

Rank Stock Value
1
NULV icon
Nuveen ESG Large-Cap Value ETF
NULV
+$30.9M
2
DBA icon
Invesco DB Agriculture Fund
DBA
+$421K
3
IAU icon
iShares Gold Trust
IAU
+$409K
4
JNJ icon
Johnson & Johnson
JNJ
+$362K
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$290K

Top Sells

Rank Stock Value
1
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$6.69M
2
HEEM icon
iShares Currency Hedged MSCI Emerging Markets
HEEM
+$6.09M
3
IGF icon
iShares Global Infrastructure ETF
IGF
+$5.4M
4
HDV
iShares Core High Dividend ETF
HDV
+$4.66M
5
EMLP icon
First Trust North American Energy Infrastructure Fund
EMLP
+$4.19M

Sector Composition

Rank Sector Weight
1 Healthcare 1.07%
2 Industrials 0.21%
3 Financials 0.18%
4 Technology 0.17%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGI icon
51
Alamos Gold
AGI
$11.9B
$100K 0.05%
14,250
– –
PRVB
52
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$84K 0.04%
21,427
-1,175
-5% -$5.57K
MREO
53
Mereo BioPharma
MREO
$49.5M
$83K 0.04%
+75,850
New +$58.8K
ANNX icon
54
Annexon
ANNX
$950M
$77K 0.04%
20,885
-1,400
-6% -$4.28K
EIGR
55
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$73K 0.04%
384
+23
+6% +$4.64K
SURF
56
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$71K 0.03%
41,688
+21,975
+111% +$45.6K
JSPR icon
57
Jasper Therapeutics
JSPR
$24.8M
$69K 0.03%
3,463
+208
+6% +$5.92K
CTMX icon
58
CytomX Therapeutics
CTMX
$788M
$67K 0.03%
35,919
+21,275
+145% +$40.7K
PSTX
59
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$61K 0.03%
23,370
-3,400
-13% -$9.45K
GERN icon
60
Geron
GERN
$924M
$59K 0.03%
34,736
-51,900
-60% -$73.3K
ORTX
61
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$58K 0.03%
9,264
-710
-7% -$4.01K
KGC icon
62
Kinross Gold
KGC
$27B
$57K 0.03%
16,000
– –
CDAK
63
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$57K 0.03%
18,310
-1,000
-5% -$3.51K
DM
64
DELISTED
Desktop Metal, Inc.
DM
$47K 0.02%
+2,131
New +$62.3K
ADAM
65
Adamas Trust
ADAM
$807M
$28K 0.01%
2,500
– –
UBX
66
DELISTED
Unity Biotechnology
UBX
$11K 0.01%
+2,038
New +$17K
DHR icon
67
Danaher
DHR
$144B
– –
-831
Closed -$216K
ESGD icon
68
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
– –
-2,833
Closed -$208K
HYG icon
69
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
– –
-5,722
Closed -$457K
OBDC icon
70
Blue Owl Capital
OBDC
$5.45B
– –
-119,827
Closed -$1.77M
REGN icon
71
Regeneron Pharmaceuticals
REGN
$70.9B
– –
-515
Closed -$353K
SSO icon
72
ProShares Ultra S&P500
SSO
$7.87B
– –
-7,320
Closed -$239K
TMO icon
73
Thermo Fisher Scientific
TMO
$198B
– –
-528
Closed -$317K
VALE icon
74
Vale
VALE
$60.4B
– –
-13,744
Closed -$275K
VMBS icon
75
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
– –
-5,720
Closed -$286K
1 2
3
4

Similar funds

NC
nVerses Capital Wellington, Florida $110M AUM
PXPO
Peak XV Partners Operations Trianon, Mauritius $110M AUM 43.09% 1-Year Est. Return
OWA
OakTrust Wealth Advisors Wilton, Connecticut $110M AUM
MCM
Masterton Capital Management New York $110M AUM 3.55% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
NA
NWM Advisors San Luis Obispo, California $110M AUM
NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
BCM
Bond Capital Management San Francisco, California $110M AUM 16.91% 1-Year Est. Return

Forefront Analytics's Q2 2022 Portfolio in Review

As of Q2 2022, Forefront Analytics held 77 positions worth $206M, down 23% from $269M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Forefront Analytics withdrew a net $30.8M in Q2 2022, closing 11 positions and reducing 39 holdings. Its most notable exit was Blue Owl Capital, an estimated $1.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.1% of assets, down from 1.1% a quarter earlier, followed by Industrials and Financials.

Against the trend, Forefront Analytics opened a new position in Nuveen ESG Large-Cap Value ETF worth $28.8M.

  • Forefront Analytics's largest Q2 2022 buy was Nuveen ESG Large-Cap Value ETF: 862,152 shares worth $28.8M.
  • Forefront Analytics added most to iShares Gold Trust in Q2 2022, an estimated $409K increase.
  • Forefront Analytics's biggest Q2 2022 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $6.69M.
  • Forefront Analytics fully exited Blue Owl Capital in Q2 2022, selling an estimated $1.77M.
  • Forefront Analytics's ten largest holdings make up 60% of its $206M portfolio in Q2 2022.
  • Forefront Analytics opened 7 new positions and closed 11 in Q2 2022.
  • Forefront Analytics's portfolio value fell 23% quarter-over-quarter to $206M.

Based on Forefront Analytics's 13F filing for Q2 2022, filed 10 Aug 2022.